Leaflet PAZOPANIB TEVA 200mg film-coated tablets
Indicated for: cancer
Route of administration: oral
Substance: pazopanib (tyrosine kinase inhibitor)
ATC: L01EX03 (Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors)
This medicine may affect fertility.
Handle with special care.
Effective contraception is required during treatment.
Do not use this medicine while breastfeeding.
Do not use this medicine during pregnancy.
Avoid grapefruit and grapefruit juice.
This medicine may affect the liver.
This medicine may have important interactions with other medicines.
This medicine may lower blood cell counts.
This medicine is subject to additional monitoring.
Periodic laboratory tests may be required during treatment.
Stop taking the medicine and seek urgent medical help if a severe rash occurs.
This medicine may increase the risk of heart rhythm disturbances.
Pazopanib is an alternative name for pazopanib, a medication used for the treatment of advanced renal cell carcinoma and soft tissue sarcoma. It acts as a tyrosine kinase inhibitor, blocking the growth of blood vessels supplying tumors and slowing cancer progression.
The medication is taken orally, usually once daily, and should be used as directed by your doctor. Regular check-ups are important to monitor the effectiveness of the treatment and any potential side effects.
Side effects may include nausea, diarrhea, high blood pressure, fatigue, or changes in liver function. In rare cases, severe reactions such as liver failure or bleeding may occur.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of pazopanib.
General data about PAZOPANIB TEVA 200mg
- Substance: pazopanib
- Date of latest medicines list: 01-06-2026
- Product code: W68756002
- Concentration: 200mg
- Pharmaceutical form: film-coated tablets
- Quantity: 60
- Product type: Generic medicine
- Price: 3563.70 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for pazopanib
- 200mg
- 400mg